International Journal of Research in Pharmacy and Allied Science

ISSN: 2583-6544   |  Issues per year: Monthly  |   Indexed In: Google Scholar, CORE, ScienceOpen, Researchgate

ISSN:2583-6544

Abstract View

Assessment of Amplitude of Accommodation (A.A) Among HIV Subjects Taking Antiretroviral Drugs (ARV)

Author(s): Ohaegbule Eberechukwu John Uzoma1, Nwakaego Ikoro2, Young Azuamah3, Victoria Nkemka4

Email(s): 1johnpimmac@gmail.com

Address:

    Department of Optometry, Federal University of Technology Owerri, Nigeria

Published In:   Volume - 5,      Issue - 2,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5204  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
The eye is a common site of manifestation of systemic diseases, particularly in immunocompromised individuals. Human immunodeficiency Virus (HIV) infection and its treatment with antiretroviral drugs (ARVs) have been associated with ocular changes, including variations in amplitude of accommodation (A.A). While antiretroviral therapy (ART) has significantly improved survival, its long-term ocular effects remain underexplored. The study assessed the amplitude of accommodation (A.A) among HIV subjects taking antiretroviral drugs (ARVs). Immunocompromised subjects on first-line ARV (ARV1) and those on second-line ARV (ARV2) show no difference in A.A. Their A.A is more likely to be affected by age, systemic health status and ocular comorbidities than the ARV they are taking. ART itself does not appear to exert a direct pharmacological effect on the accommodative apparatus of the eye. The mean amplitude of accommodation was 7.62D among subjects on first-line ARV and 9.61D among those on second-line ARV, with no significant difference between the two groups and with P value = 1.00. There was no difference in A.A between immunocompromised subjects taking ARV1 and ARV2.

Keywords:

Cite this article:
Ohaegbule Eberechukwu John Uzoma, Nwakaego Ikoro, Young Azuamah, Victoria Nkemka. Assessment of Amplitude of Accommodation (A.A) Among HIV Subjects Taking Antiretroviral Drugs (ARV). IJRPAS, February 2026; 5(2): 35-47.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5204


1.        Obi, C.C. (2008/09). EMDEX, The Compl Drug Form for Nigeria’s Health Proffs.

2.        Broder, T., Rodway, N., Hayward, A. and Harris, N. (2008). The Brit Med Ass, Illustr Med Dict

3.        Ngondi, L.J., Mbouobda, H.D., Fonkoua, M., Nouemsi, A.P.K. and Oben, J. (2007). The Long-term Effect of Different Combination Therapies on Glucose Metabolism in HIV/AIDS Subjects in Cameroon. J of Med Sci7:609-614.

4      Avari, P., Devendra, S. (2017). Human immunodeficiency virus and type 2 diabetes. London J Prim Care(Abingdon); 9(3):38-42.

5   Bam, N.E., Maunda, S.A., Ntsaba, J., Apalata, T., Nomatshila, S.C. and Chitha, W. (2020). The association between HIV tri-therapy with the development of Type-2 Diabetes Mellitus in a rural South African District: Acase-control study. PLoS ONE 15(12):e0244067. 

6   Fiseha, T., Belete, A.G., Dereje, H., Dires, A. (2019). Hypertension in HIV-Infected Patients Receiving Antiretroviral Therapy in Northeast Ethiopia. Inter J of Hyperten 2019(4103604).

7   Fahme, S.A., Bloomfield, G.S. and Peck,R. (2018). Hypertension in HIV-Infected Adults- Novel Pathophysiologic Mechanisms. Hyperten 72:44-55

8   Musekwa, R., Hamooya, B.M., Koethe, J.R., Nzela, S. and Masenga, S.K. (2021). Prevalence and correlates of hypertension in HIV-positive adults from the Livingstone Central Hospital, Zambia. Pan Afr Med J. 39:237.

9 Abbey,S. (2022). High blood pressure and HIV [online]. Available at: https://www.aidsmap.com/(Accessed: 4 March 2023)

10   Milburn, J., Jones, R., and Levy, J.B. (2017). Renal effects of novel antiretroviral drugs. Nephrol Dial Transplant 32(3):434-439.

11    Yves, M.EL.M.,Verland, W.G., Cebrael, P.A.M. (2021). Effect of Antiretrovirals on Renal Function of HIV/AIDS Patients at Two Hospitals in Yaounde, Cameroon. J ClinNephrolRen Care 7(064):2572-3286

12    Kabore̕, N.F., Poda, A., Zooungrana, J., Da, O., Ciaffi, L., Semde̕, A., Yame̕ogo, I., Sawadogo, A.B., Delaporte, E., Meda, N., Limou, S. and Cournil, A. (2019). Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a West African setting. BioMedCentral Nephrol 20(155)

13   Chwiki, S., Campos, M.M., McLaughlin, M.E., Kleiner, D.E., Kovacs, J.A., Morse, C.G., and Abu-Asab, M.S. (2017). Adverse Effects of Antiretroviral Therapy on Liver Hepatocytes and Endothelium in HIV Patients: an Ultrastructural Perspective. UltrastructPathol. 41(2): 186-195.

14     Toulouse, B. and Learned, J. (2002). Antiretrovirals and Liver Toxicity: How Big a Concern? AIDS Comm Res Initiat of Amr.

15  Tesfa, E., Siefu, D., Belayneh, Y., and Mekonnen, Z. (2019). Liver enzyme elevation in patients taking HAART compared with treatment naïve controls at DebreBerhan Referral Hospital: a comparative cross-sectional study, Northeast Ethiopia. BioMedCentral Res Notes 12(714).

16   Lucien, K.F.H., Clement, A.N.J., Fon, N.P., Weledji, P. and Ndikvu, C.P. (2010). The Effects of Antiretroviral Treatment on Liver Function Enzymes Among HIV-Infected Out Patients Attending The Central Hospital of Yaounde, Cameroon. Afr. J. Cln. Exper. Microbiol11(3): 174-178

17   Venkatesh, K.K., Biswas, J., Kumarasamy, N. (2008). Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus/acquired immune deficiency syndrome. Indian J Ophthalmol 56(5):391-393.

18    Mishra, N. (2017). Study of amplitude of accommodation in patient with Human Immunodeficiency Virus infection on AntiRetrovirus Treatment. J of Med Sci and Clin Res.5(6)

19    Pathai, S., Lawn, S.D., Weiss, H.A., Cook, C., Bekker, Linda-Gail., and Gilbert, C.E. (2013). Retinal Nerve Fibre Layer Thickness and Contrast Sensitivity in HIV-infected Individuals in South Africa: A Case-Control Study. PLos One 8(9):e73694. [online]. Available at: www.ncbi.nlm.nih.gov

20  Mathebula, S.D. and Makunyane, P.S. (2017). Loss of amplitude of accommodation in pre-presbyopic HIV and AIDS patients under treatment with antiretrovirals. Afr Vis and Eye Health J 76(1)

21  Cravo, L.M.S., Biancardi, A.L., Ronconi, T.B., Xavier, V.L., and Moares Jr., H. (2019). Intraocular pressure in patients with human immunodeficiency virus, correlation with TCD4, viral load and demographic characteristics: a case-control study. ClinOphthalmol13:1477-1483.

Related Images:



Recent Images



Green Synthesized Zinc Oxide Nanoparticles from Mimusops elengi Flowers: UV Characterization and Antidiabetic Potential
From Mist to Medicine: Wound healing Revolution with Liquid Sprays
Development and Evaluation of Monoherbal Fast Dissolving Oral Film (FDOF) From The Root Extract of Achyranthes aspera Linn for the Treatment of Snake Bites
Plastic Blood: Synthetic Blood Substitutes in Emergency Medicine for Patient Transfusion
Multi-Model AI-Assisted Early Detection of Oral Cancer Integrated With Phytochemical Profiling, Antioxidant , And In-Silico Target Evaluation of Boerhavia diffusa Linn
Assessment of Amplitude of Accommodation (A.A) Among HIV Subjects Taking Antiretroviral Drugs (ARV)
A Systematic Review of Botany, Traditional Uses, Phytochemistry and Pharmacology of Different Alstonia Species
CRISPR-Cas Systems in Targeted Drug Delivery and Gene Therapy: An Emerging Approach to Precision Medicine
Evaluation of In-vitro Anti-diabetic activity in Ethanolic Stem Extract of Euphobia hirta
Evolving Landscape of Medical Device Vigilance in India: Current Status and Future Directions of MvPI

Tags


Quick Links


Latest Issues

Popular Articles